44.42
Guardant Health Inc 주식(GH)의 최신 뉴스
What catalysts could drive Guardant Health Inc. stock higher in 2025Invest smarter and grow your wealth faster - jammulinksnews.com
Should I hold or sell Guardant Health Inc. stock in 2025Beginner Investor Alerts For Fast Growth - jammulinksnews.com
Lobbying Update: $241,000 of GUARDANT HEALTH lobbying was just disclosed - Quiver Quantitative
What are the latest earnings results for Guardant Health Inc.Extraordinary earning power - jammulinksnews.com
What institutional investors are buying Guardant Health Inc. stockUnlock expert market analysis instantly - jammulinksnews.com
How volatile is Guardant Health Inc. stock compared to the marketBuild a portfolio for long-term financial success - jammulinksnews.com
What are Guardant Health Inc. company’s key revenue driversCapitalize on emerging market sectors - jammulinksnews.com
What makes Guardant Health Inc. stock price move sharplyCapital Safe Stock Watchlist - Metal.it
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
Guardant Health Enrolls First Patient in NCI Vanguard Study for Multi-Cancer Detection Test - MSN
What drives Guardant Health Inc. stock priceConsistent wealth multiplication - PrintWeekIndia
What analysts say about Guardant Health Inc. stockTremendous growth potential - PrintWeekIndia
Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem - GlobeNewswire Inc.
Is Guardant Health Inc. a good long term investmentDynamic growth stocks - PrintWeekIndia
1 Healthcare Stock with Solid Fundamentals and 2 We Avoid - Yahoo Finance
10 Best Mid Cap Pharma Stocks to Buy - Insider Monkey
Colonoscopies are no fun. These at-home colon cancer screenings offer a shortcut. - Business Insider
Guardant Health (NASDAQ:GH investor five-year losses grow to 44% as the stock sheds US$228m this past week - Yahoo Finance
Guardant Health Inc. Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com
3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance
Cathie Wood’s ARK ETFs shift focus, buying NVIDIA and selling GUARDANT - Investing.com
Freenome's new CEO is ready to compete in race for tests that can detect cancer early - The Business Journals
Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - Benzinga
Guardant Health (GH): director Tariq Musa sells $5591 in stock By Investing.com - Investing.com South Africa
Guardant Health (GH): director Tariq Musa sells $5591 in stock - Investing.com
Guardant Health Director Sells 142 Shares at $48.2 Per Share on 2025-07-17. - AInvest
Global Liquid Biopsy Market Size Worth USD 25.24 Billion By 2032 | - openPR.com
Lung Cancer Diagnostics Market Expansion Driven by Liquid - openPR.com
자본화:
|
볼륨(24시간):